Aptose to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies

September 16, 2019 sandiegobiotech News Comments Off on Aptose to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies
Aptose to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies
/

SAN DIEGO and TORONTO, Sept. 16, 2019 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (?Aptose? or the ?Company?) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that William G. Rice, Chairman, Ph.D., President and Chief Executive Officer, Gregory K. Chow, Executive Vice President and Chief Financial Officer and Jotin Marango, M.D., Ph.D., Senior Vice President and Chief Business Officer, will participate in Oppenheimer & Co. Inc.?s Fall Summit Focused on Specialty Pharma and Rare Disease Companies on September 23, 2019 in New York.

Related Articles

No Picture
News

Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019

July 24, 2019 sandiegobiotech News Comments Off on Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019

SAN DIEGO and TORONTO, July 23, 2019 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes and signaling pathways of cancer… […]

No Picture
News

Aptose to Present at the Piper Sandler 33rd Annual Healthcare Conference

November 22, 2021 sandiegobiotech News Comments Off on Aptose to Present at the Piper Sandler 33rd Annual Healthcare Conference

SAN DIEGO and TORONTO, Nov. 22, 2021 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that the Aptose management team will be participating in the Piper Sandler 33rd Annual Healthcare Conference,… Click here to view original post… […]

No Picture
News

Aptose to Report Second Quarter 2021 Financial Results and Hold Conference Call on Tuesday, August 3, 2021

July 20, 2021 sandiegobiotech News Comments Off on Aptose to Report Second Quarter 2021 Financial Results and Hold Conference Call on Tuesday, August 3, 2021

SAN DIEGO and TORONTO, July 20, 2021 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, will report financial results for the quarter ended June 30, 2021, and provide a corporate update on Tuesday,… Click here to view original post… […]